Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Mittelman

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Leukemia Research|May 15, 2012
Erythropoietin: the swinging pendulumHoward S Oster, Drorit Neumann, Michael Hoffman, et al.
Leukemia Research|June 25, 2010
The lower risk MDS patient at risk of rapid progressionMoshe Mittelman, Howard S Oster, Michael Hoffman, et al.
Haematologica|October 24, 2024
Diagnosis of myelodysplastic syndromes: the classic and the novelHoward S Oster, Arjan A Van de Loosdrecht, Moshe Mittelman
Harefuah|January 24, 2014
[Decitabine treatment in myelodysplastic syndromes--results of a compassionate patient program in Israel]Abraham Klepfish, Itay Silbershatz, Gilles Lugassy, et al.
European Journal of Internal Medicine|July 13, 2004
Clinical and ethnic characteristics of stroke in an Israeli population: a study in a community hospital populationAliza Zeidman, Yaacov Levine, Zinaida Fradin, et al.
Haematologica|July 3, 2010
Macrophages as novel target cells for erythropoietinLilach Lifshitz, Galit Tabak, Max Gassmann, et al.
Frontiers in Medicine|July 28, 2025
Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromesReut Hausman, Roi Gat, Noa Goldschmidt, et al.
The Israel Medical Association Journal : IMAJ|December 16, 2015
Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic SyndromeUri Rozovski, Ofira Ben-Tal, Ilya Kirgner, et al.
Experimental Hematology|October 17, 2008
Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?Sara Prutchi Sagiv, Lilach Lifshitz, Ruth Orkin, et al.
The Israel Medical Association Journal : IMAJ|December 24, 2003
Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adultsValery Teplitsky, David Huminer, Joseph Zoldan, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Leukemia Research|May 15, 2012
Erythropoietin: the swinging pendulumHoward S Oster, Drorit Neumann, Michael Hoffman, et al.
Leukemia Research|June 25, 2010
The lower risk MDS patient at risk of rapid progressionMoshe Mittelman, Howard S Oster, Michael Hoffman, et al.
Haematologica|October 24, 2024
Diagnosis of myelodysplastic syndromes: the classic and the novelHoward S Oster, Arjan A Van de Loosdrecht, Moshe Mittelman
Harefuah|January 24, 2014
[Decitabine treatment in myelodysplastic syndromes--results of a compassionate patient program in Israel]Abraham Klepfish, Itay Silbershatz, Gilles Lugassy, et al.
European Journal of Internal Medicine|July 13, 2004
Clinical and ethnic characteristics of stroke in an Israeli population: a study in a community hospital populationAliza Zeidman, Yaacov Levine, Zinaida Fradin, et al.
Haematologica|July 3, 2010
Macrophages as novel target cells for erythropoietinLilach Lifshitz, Galit Tabak, Max Gassmann, et al.
Frontiers in Medicine|July 28, 2025
Neutropenia (even mild) and anemia are poor prognostic factors in myelodysplastic syndromesReut Hausman, Roi Gat, Noa Goldschmidt, et al.
The Israel Medical Association Journal : IMAJ|December 16, 2015
Increased Incidence of Red Blood Cell Alloantibodies in Myelodysplastic SyndromeUri Rozovski, Ofira Ben-Tal, Ilya Kirgner, et al.
Experimental Hematology|October 17, 2008
Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?Sara Prutchi Sagiv, Lilach Lifshitz, Ruth Orkin, et al.
The Israel Medical Association Journal : IMAJ|December 24, 2003
Hereditary partial transcobalamin II deficiency with neurologic, mental and hematologic abnormalities in children and adultsValery Teplitsky, David Huminer, Joseph Zoldan, et al.
Pageof 12